Slate Path Capital LP - Q3 2020 holdings

$1.76 Billion is the total value of Slate Path Capital LP's 26 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 51.5% .

 Value Shares↓ Weighting
CHTR  CHARTER COMMUNICATIONS INC Ncl a$210,403,000
+22.4%
337,0000.0%11.97%
+18.1%
MOS BuyMOSAIC CO NEW$151,641,000
+54.3%
8,300,000
+5.7%
8.63%
+48.8%
GOLD SellBARRICK GOLD CORP$151,597,000
-9.5%
5,393,000
-13.3%
8.63%
-12.7%
NYT  NEW YORK TIMES COcl a$151,477,000
+1.8%
3,540,0000.0%8.62%
-1.8%
MYL  MYLAN NV$151,192,000
-7.8%
10,195,0000.0%8.60%
-11.0%
WMG BuyWARNER MUSIC GROUP CORP$150,310,000
+1.9%
5,230,000
+4.6%
8.55%
-1.7%
PAAS  PAN AMERN SILVER CORP$133,744,000
+5.8%
4,160,0000.0%7.61%
+2.0%
FCX  FREEPORT-MCMORAN INCcl b$117,769,000
+35.2%
7,530,0000.0%6.70%
+30.4%
SNAP SellSNAP INCcl a$113,970,000
+5.8%
4,365,000
-4.8%
6.48%
+2.1%
Z SellZILLOW GROUP INCcl c cap stk$78,529,000
-32.9%
773,000
-61.9%
4.47%
-35.2%
LBRDK NewLIBERTY BROADBAND CORP$74,292,000520,000
+100.0%
4.23%
SFIX NewSTITCH FIX INC$69,588,0002,565,000
+100.0%
3.96%
KEX  KIRBY CORP$46,876,000
-32.5%
1,296,0000.0%2.67%
-34.9%
CYCN BuyCYCLERION THERAPEUTICS INC$37,672,000
+432.9%
6,196,063
+418.0%
2.14%
+414.1%
VAPO NewVAPOTHERM INC$35,438,0001,221,993
+100.0%
2.02%
ALNY SellALNYLAM PHARMACEUTICALS INC$31,013,000
-64.1%
213,000
-63.5%
1.76%
-65.4%
CUE BuyCUE BIOPHARMA INC$22,328,000
+4.6%
1,483,619
+70.4%
1.27%
+0.9%
GPRE  GREEN PLAINS INC$7,353,000
+51.5%
475,0000.0%0.42%
+46.2%
CNX  CNX RES CORP$4,720,000
+9.1%
500,0000.0%0.27%
+5.5%
FVAC NewFORTRESS VALUE ACQUISITION C$4,481,000330,000
+100.0%
0.26%
LX NewLEXINFINTECH HLDGS LTDadr$4,076,000595,000
+100.0%
0.23%
EEM  ISHARES TRcall$2,689,000
+10.3%
61,0000.0%0.15%
+6.2%
CCJ  CAMECO CORP$1,717,000
-1.5%
170,0000.0%0.10%
-4.9%
RIG  TRANSOCEAN LTD$1,670,000
-55.9%
2,070,0000.0%0.10%
-57.4%
KGC  KINROSS GOLD CORP$1,588,000
+22.2%
180,0000.0%0.09%
+16.9%
IAG  IAMGOLD CORP$1,341,000
-3.0%
350,0000.0%0.08%
-7.3%
MR ExitMONTAGE RES CORP$0-370,000
-100.0%
-0.09%
GPORQ ExitGULFPORT ENERGY CORP$0-1,860,000
-100.0%
-0.12%
APRN ExitBLUE APRON HLDGS INCcl a new$0-297,000
-100.0%
-0.19%
SWN ExitSOUTHWESTERN ENERGY CO$0-2,100,000
-100.0%
-0.32%
ATRA ExitATARA BIOTHERAPEUTICS INC$0-420,000
-100.0%
-0.36%
RRC ExitRANGE RES CORP$0-1,200,000
-100.0%
-0.40%
ZG ExitZILLOW GROUP INCcl a$0-185,000
-100.0%
-0.63%
BKR ExitBAKER HUGHES COMPANYcl a$0-1,175,000
-100.0%
-1.07%
EQT ExitEQT CORP$0-1,670,000
-100.0%
-1.17%
NOV ExitNATIONAL OILWELL VARCO INC$0-1,645,000
-100.0%
-1.19%
IRWD ExitIRONWOOD PHARMACEUTICALS INC$0-2,640,000
-100.0%
-1.61%
GDXJ ExitVANECK VECTORS ETF TRjr gold miners e$0-685,000
-100.0%
-2.00%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2020-11-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CHARTER COMMUNICATIONS INC N30Q3 202315.2%
ALNYLAM PHARMACEUTICALS INC30Q3 20208.9%
UNITED STATES STL CORP NEW24Q3 202311.4%
NEW YORK TIMES CO23Q3 202310.9%
VANECK VECTORS ETF TR21Q3 202319.5%
PAN AMERN SILVER CORP21Q3 20237.6%
CUE BIOPHARMA INC17Q3 20231.3%
BARRICK GOLD CORPORATION16Q4 202015.7%
MOSAIC CO NEW15Q4 202116.8%
MEDICINES CO15Q4 201912.2%

View Slate Path Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Slate Path Capital LP Q3 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
Cue Biopharma, Inc.February 14, 20232,402,4555.6%
Stitch Fix, Inc.February 14, 2023? ?
Cyclerion Therapeutics, Inc.January 13, 20237,157,60116.5%
Zimmer Energy Transition Acquisition Corp.February 14, 20222,000,0005.8%
5:01 Acquisition Corp.February 11, 2022500,0005.8%
Hippo Holdings Inc.February 11, 2022350,0000.1%
Warner Music Group Corp.February 11, 20223,134,7792.6%
Reinvent Technology Partners ZFebruary 16, 20211,750,0007.6%

View Slate Path Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
SC 13G/A2024-01-22
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
SC 13G/A2023-02-14
SC 13G2023-02-14
13F-HR2023-02-14
SC 13G2023-01-13
SC 13G2022-11-18

View Slate Path Capital LP's complete filings history.

Compare quarters

Export Slate Path Capital LP's holdings